Related Experiment Video
Updated: Nov 3, 2025

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Mutant p53 Mediates Sensitivity to Cancer Treatment Agents in Oesophageal Adenocarcinoma Associated with MicroRNA and
Ann-Kathrin Eichelmann1,2, George C Mayne1,3, Karen Chiam1
1Flinders Health and Medical Research Institute-Cancer Program, Flinders University, Bedford Park, Adelaide, SA 5042, Australia.
Abstract:
TP53 gene mutations occur in 70% of oesophageal adenocarcinomas (OACs). Given the central role of p53 in controlling cellular response to therapy we investigated the role of mutant (mut-) p53 and SLC7A11 in a CRISPR-mediated JH-EsoAd1 TP53 knockout model. Response to 2 Gy irradiation, cisplatin, 5-FU, 4-hydroxytamoxifen, and endoxifen was assessed, followed by a TaqMan OpenArray qPCR screening for differences in miRNA expression. Knockout of mut-p53 resulted in increased chemo- and radioresistance (2 Gy survival fraction: 38% vs. 56%, p < 0.0001) and in altered miRNA expression levels. Target mRNA pathways analyses indicated several potential mechanisms of treatment resistance. SLC7A11 knockdown restored radiosensitivity (2 Gy SF: 46% vs. 73%; p = 0.0239), possibly via enhanced sensitivity to oxidative stress. Pathway analysis of the mRNA targets of differentially expressed miRNAs indicated potential involvement in several pathways associated with apoptosis, ribosomes, and p53 signaling pathways. The data suggest that mut-p53 in JH-EsoAd1, despite being classified as non-functional, has some function related to radio- and chemoresistance. The results also highlight the important role of SLC7A11 in cancer metabolism and redox balance and the influence of p53 on these processes. Inhibition of the SLC7A11-glutathione axis may represent a promising approach to overcome resistance associated with mut-p53.
Insights
Mutant TP53 gene in esophageal adenocarcinoma promotes resistance to chemotherapy and radiation. Inhibiting SLC7A11 may overcome this resistance, offering new therapeutic strategies for OAC patients.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Genetics
Background:
- TP53 gene mutations are prevalent in esophageal adenocarcinoma (OAC).
- Mutant p53 influences cellular response to cancer therapies.
- SLC7A11's role in cancer metabolism and redox balance is under investigation.
Purpose of the Study:
- To investigate the role of mutant p53 and SLC7A11 in OAC treatment resistance.
- To analyze the impact of TP53 knockout on cellular response to various therapies.
- To identify miRNA expression changes and related pathways in OAC models.
Main Methods:
- CRISPR-mediated TP53 knockout in JH-EsoAd1 OAC cell line.
- Assessment of cellular response to irradiation and chemotherapies (cisplatin, 5-FU).
- TaqMan OpenArray qPCR for miRNA expression profiling and pathway analysis.
Main Results:
- TP53 knockout increased resistance to chemo- and radiotherapy.
- miRNA expression levels were altered post-knockout.
- SLC7A11 knockdown restored radiosensitivity, potentially via enhanced oxidative stress sensitivity.
Conclusions:
- Mutant p53, even if non-functional, contributes to radio- and chemoresistance in OAC.
- SLC7A11 plays a significant role in cancer metabolism and redox balance, influenced by p53.
- Targeting the SLC7A11-glutathione axis is a promising strategy to overcome mut-p53-associated resistance.
More Related Videos
Related Concept Videos
Abnormal Proliferation
MicroRNAs
MicroRNAs
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Induced Pluripotent Stem Cells
Somatic...

